AVID RADIOPHARMACEUTICALS Trademark

Trademark Overview


On Friday, April 15, 2022, a trademark application was filed for AVID RADIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the AVID RADIOPHARMACEUTICALS trademark a serial number of 97360821. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Avid Radiopharmaceuticals, Inc.. The AVID RADIOPHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic agents, preparations and substances containing radioactive agents for medical purposes; radioactive diagnostic scanning agents for in vivo use for detection and monitoring of beta-amyloid plaque; radiopharmaceutical preparations for clinical, medical and research use for diagnosing and treating brain diseases and disorders in the field of brain plaque density; radioactive pharmaceutical preparations and non-radioactive medical reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use for diagnosing and treating brain diseases and disorders; radiopharmaceutical preparations for use in diagnosis of Alzheimer's disease
avid radiopharmaceuticals

General Information


Serial Number97360821
Word MarkAVID RADIOPHARMACEUTICALS
Filing DateFriday, April 15, 2022
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7014191
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesDiagnostic agents, preparations and substances containing radioactive agents for medical purposes; radioactive diagnostic scanning agents for in vivo use for detection and monitoring of beta-amyloid plaque; radiopharmaceutical preparations for clinical, medical and research use for diagnosing and treating brain diseases and disorders in the field of brain plaque density; radioactive pharmaceutical preparations and non-radioactive medical reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use for diagnosing and treating brain diseases and disorders; radiopharmaceutical preparations for use in diagnosis of Alzheimer's disease
Disclaimer with Predetermined Text"RADIOPHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 9, 2022
Primary Code005
First Use Anywhere DateTuesday, October 25, 2022
First Use In Commerce DateTuesday, October 25, 2022

Trademark Owner History


Party NameAvid Radiopharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Party NameAvid Radiopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Party NameAvid Radiopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, February 18, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 17, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 10, 2023USE AMENDMENT FILED
Wednesday, February 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 10, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, June 17, 2022ASSIGNED TO EXAMINER
Monday, June 13, 2022ASSIGNED TO EXAMINER
Monday, May 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2022NEW APPLICATION ENTERED